Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,107.49
(
-0.26%
)
US TECH 100
25,840.80
(
-0.44%
)
Dow Jones
49,431.69
(
-0.03%
)
Brent Oil
91.84
(
-0.89%
)
Bitcoin
75,804.25
(
2.63%
)
News Focus
News Focus
Post# of 15767
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

tnzalu

Send PM Follow Ignore
Followers 27
Posts 2221
Boards Moderated 0
Alias Born 09/04/2009

tnzalu

Re: None

Monday, 01/04/2010 3:26:28 PM

Monday, January 04, 2010 3:26:28 PM

Post# of 15767
I added more here this morning, from .35ish down to .29. My valuation of ANX is based on their ability to sell the company by proving out the re-emulsified drug. The dilutive offering will help them do this, and it is better to get it over with now. $19mm in dilution to support a $200mm (plus?) oncology asset is easy math.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today